Results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study were released at a session at the 9th South African AIDS Conference (SA AIDS 2019) in Durban, South Africa, on Thursday, June 13th. The session, which included presentations on the primary analysis, was recorded and can be viewed on YouTube here.
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label randomised clinical trial comparing three highly effective, reversible methods of contraception — a progestogen-only injectable called depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant and the non-hormonal copper intrauterine device — to evaluate whether there is any difference in the risk of acquiring HIV infection among users of these methods.Read this fact sheet for more about the ECHO study.
The Southern Africa HIV and AIDS Regional Exchange (SHARE) was first developed in 2011 to address the need for a free, user-friendly space for online knowledge sharing of locally-relevant HIV and AIDS information. Since its inception, SHARE has connected thousands of people to resources, peers, organizations, online learning, and tools for collaboration. Almost daily, SHARE posts new content to its social media profiles on Facebook and Twitter to further amplify what the platform has to offer. SHARE’s experiences have led to a new wealth of knowledge on what it takes to lead a successful social media strategy. Presented here are a few tips based on what has worked for us.
It makes logical sense that integrating SRHR and HIV services should be cost effective and some studies have found clear efficiencies in the use of human resources for health (Integra and the Together4SRHR).